Market Overview

Stocks Hitting 52-Week Highs

Share:
Related VRTX
Vertex Pharmaceuticals' Phase 3 Studies Offer Ample Opportunity For Upside
Earnings Scheduled For July 27, 2016
Related IDXX
Canaccord Fireside Chat Takeaways For Abaxis, Heska
18 Biggest Mid-Day Gainers For Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) shares reached a new 52-week high of $95.02 after the company reported that its two phase 3 study of Lumacaftor in combination with ivacaftor met the primary endpoint.

IDEXX Laboratories (NASDAQ: IDXX) gained 2.19% to reach a new 52-week high of $135.53. Canaccord Genuity upgraded IDEXX from Hold to Buy and raised the price target from $116.00 to $148.00.

Intel (NASDAQ: INTC) shares rose 0.69% to touch a new 52-week high of $30.44. Intel's trailing-twelve-month revenue is $52.89 billion.

Yum! Brands (NYSE: YUM) shares gained 0.24% to touch a new 52-week high of $80.80. Yum's PEG ratio is 1.56.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (IDXX + INTC)

View Comments and Join the Discussion!